Suchergebnisse - "Shankaran, Veena"

PubPharm (126)

71

Drug Price Inflation and the Cost of Assisted Death for Terminally Ill Patients-Death With Indignity

enthalten in: JAMA oncology | 2017

von Shankaran, V. | LaFrance, R. | Ramsey, S.

CommentIn: JAMA Oncol. 2017 Aug 1;3(8):1137. - PMID 28542674

72

IFN-[gamma]-related mRNA profile predicts clinical response to PD-1 blockade.(RESEARCH ARTICLE)(interferons )(messenger RNA )

enthalten in: The journal of clinical investigation | 2017

von Ayers, M. | Lunceford, J. | Nebozhyn, M. | +12

73

CD200 Expression in Neuroendocrine Neoplasms

enthalten in: American journal of clinical pathology | 2017

von Love, J. | Thompson, K. | Kilgore, M. | +10

74

Proton therapy posterior beam approach with pencil beam scanning for esophageal cancer : Clinical outcome, dosimetry, and feasibility

enthalten in: Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al | 2016

von Zeng, Y. | Vyas, S. | Dang, Q. | +7

75

31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part one

enthalten in: Journal for ImmunoTherapy of Cancer | 2016

von Lundqvist, A. | van Hoef, V. | Zhang, X. | +1758

76

31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part one

enthalten in: Journal for ImmunoTherapy of Cancer | 2016

von Lundqvist, A. | van Hoef, V. | Zhang, X. | +1758

77

Proton therapy posterior beam approach with pencil beam scanning for esophageal cancer

enthalten in: Strahlentherapie und Onkologie | 2016

von Zeng, Y. | Vyas, S. | Dang, Q. | +7

78

Proton therapy posterior beam approach with pencil beam scanning for esophageal cancer

enthalten in: Strahlentherapie und Onkologie | 2016

von Zeng, Y. | Vyas, S. | Dang, Q. | +7

79

Proton therapy posterior beam approach with pencil beam scanning for esophageal cancer

enthalten in: Strahlentherapie und Onkologie | 2016

von Zeng, Y. | Vyas, S. | Dang, Q. | +7

80

Pembrolizumab for patients with PD-L1-positive advanced gastric cancer (KEYNOTE-012) : a multicentre, open-label, phase 1b trial

enthalten in: The Lancet. Oncology | 2016

von Muro, K. | Chung, H. | Shankaran, V. | +15

CommentIn: Lancet Oncol. 2016 Jun;17 (6):682-683. - PMID 27157490